Enzon Pharmaceuticals, Inc.
ENZN
$0.06
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.58% | -2.34% | -1.49% | -4.04% | 0.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -41.85% | -7.43% | -20.00% | 89.42% | -13.06% |
| Total Current Assets | -1.96% | -2.39% | -1.72% | -3.46% | 0.39% |
|
|
|||||
| Total Current Assets | -1.96% | -2.39% | -1.72% | -3.46% | 0.39% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -38.10% | -- | -- | -94.44% |
| Total Assets | -2.01% | -2.43% | -1.63% | -3.49% | -0.23% |
|
|
|||||
| Total Accounts Payable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Accrued Expenses | -37.31% | 8.06% | -71.82% | 205.56% | -28.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 152.11% | -65.37% | 13,566.67% | -99.76% | 21,150.00% |
| Total Other Current Liabilities | 152.11% | -65.37% | 13,566.67% | -99.76% | 21,150.00% |
| Total Current Liabilities | 35.37% | -32.75% | 44.95% | -66.98% | 283.11% |
|
|
|||||
| Total Current Liabilities | 35.37% | -32.75% | 44.95% | -66.98% | 283.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 35.37% | -32.75% | 44.95% | -66.98% | 283.11% |
|
|
|||||
| Common Stock & APIC | -0.74% | -0.74% | -0.73% | -0.73% | 0.44% |
| Retained Earnings | -1.48% | -1.15% | -1.41% | -0.75% | -0.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -173.56% | -313.66% | -77.88% | -35.07% | 8.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.20% | 1.22% | 1.23% | 1.25% | -3.61% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.20% | 1.22% | 1.23% | 1.25% | -3.61% |
|
|
|||||
| Total Common Equity | -173.56% | -313.66% | -77.88% | -35.07% | 8.91% |
| Total Preferred Equity | 1.20% | 1.22% | 1.23% | 1.25% | -3.61% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.48% | -1.87% | -2.20% | -1.15% | -2.88% |
|
|
|||||